Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

Take Advantage Of The ‘Summer Dip’ With The FTSE 100, AstraZeneca plc & Vodafone Group plc

Now could be a great time to buy AstraZeneca plc (LON: AZN), Vodafone Group plc (LON: VOD) and the FTSE 100 (INDEXFTSE:UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100

‘Sell in May and don’t come back until St. Ledger’s day’ is a well-known saying in investing circles. Indeed, data from recent decades seems to back it up: the stock market rarely embarks on a sustained summer rally and usually falls between May and September. This has been the case in 2014, with the FTSE 100 falling by 1% over the last three months.

This means that the index is flat for the year so far, although it still appears to offer good value for money when compared to its American cousin, the S&P 500. While it trades on a price to earnings (P/E) ratio of 18.5, our FTSE 100 has a P/E of just 13.4. So, while many commentators have been getting excited about our ‘summer dip’ in terms of it being the beginning of a prolonged market correction, it could turn out to be little more than a mild, mundane and entirely predictable summer pullback.

Great Value

As a result of falls in the last few months, many top-notch FTSE 100 stocks are now even better value than they were in May. Two fine examples are AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD). The former has fallen by 1.5% during the last three months, while the latter is down 7% over the same time period. This means that both companies now offer above-average yields of 4% and 5.7% respectively, which highlights their attractive valuations at current price levels.

Looking Ahead

However, there is a lot more to AstraZeneca and Vodafone that attractive prices. For example, AstraZeneca continues to make huge improvements to its drug pipeline and is gradually overcoming a sizeable patent cliff that has caused the company’s top and bottom lines to fall in recent years. Similarly, Vodafone is pursuing a sound strategy of buying undervalued assets in Europe. Although it may take many years for this strategy to come good, it looks set to put Vodafone on a long term path to strong growth and stability, which is great news for shareholders.

Certainly, the ‘summer dip’ may not yet be over. The FTSE 100, including AstraZeneca and Vodafone, may fall further. However, they seem to offer top notch value for money at present and appear to have bright futures. Indeed, with the UK economy continuing to pick up pace, and with interest rates looking less likely to move higher as a result of lower than expected inflation, a purple patch could be just around the corner. As a result, it could be worth coming back a little before St. Ledger’s day!

Peter Stephens owns shares of AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 Warren Buffett investing ideas I plan to use in 2026

After decades in the top job at Berkshire Hathaway, Warren Buffett is preparing to step aside. But this writer will…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

Looking to earn a second income next year (and every year)? Here’s one approach.

Christopher Ruane explains how some prudent investment decisions now could potentially help set someone up with a second income in…

Read more »

Senior woman potting plant in garden at home
Investing Articles

Could a 10%+ yielding dividend share like this make sense for a retirement portfolio?

With a double-digit percentage yield, could this FTSE 250 share be worth considering for a retirement portfolio? Our writer weighs…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Forget Rigetti and IonQ: here’s a quantum computing growth stock that actually looks cheap

Edward Sheldon has found a growth stock in the quantum computing space with lots of potential and a really attractive…

Read more »

UK money in a Jar on a background
Investing Articles

Here’s a £3 a day passive income plan for 2026!

Looking for a simple and cheap plan to try and earn passive income in 2026 and beyond? Christopher Ruane shares…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

NIO stock’s down 35% since October. Time to buy?

NIO stock has had a roller coaster year so far! Christopher Ruane looks at some of the highs and lows…

Read more »

Investing Articles

By December 2026, £1,000 invested in BAE Systems shares could be worth…

Where will BAE Systems shares be in a year's time? Here is our Foolish author's review of the latest analyst…

Read more »

Mature people enjoying time together during road trip
Investing Articles

Keen for early retirement with a second income from dividends? Here’s how much you might need to invest

Ditching the office job early is a dream of many, but without a second income, is it possible? Here’s how…

Read more »